Skip to content
Open access

Simultaneous HPLC-UV quantification of donepezil and rivastigmine in human plasma using an SBA-15/graphene oxide nanocomposite based DLLME dSPE approach

Sep 2026 · Turkish journal of analytical chemistry · 0 citations · 27 references

Abstract

This study aimed to develop and validate a sensitive, environmentally friendly analytical method for the simultaneous quantification of donepezil and rivastigmine in human plasma to support therapeutic drug monitoring (TDM). The approach combined a novel dispersive solid-phase extraction (dSPE) utilizing a purposely synthesized SBA-15/graphene oxide (GO) nanocomposite characterized by FT-IR, SEM, and TGA with dispersive liquid-liquid microextraction (DLLME), followed by HPLC-UV detection. Critical parameters affecting extraction efficiency, including sorbent amount, desorption/disperser solvent, sample pH, equilibration time, and ionic strength, were systematically optimized, and the method was validated according to ICH M10 and FDA (2018) guidelines. The optimized SBA-15/GO nanocomposite displayed a highly ordered mesoporous structure with an average pore diameter of 66.77 nm, with optimal extraction achieved using 0.001 g of sorbent, acetonitrile as the desorption/disperser solvent, a sample pH of 6.0, a 30-minute equilibration time, and no salt addition. The method exhibited excellent linearity over 0.15–200 µg/mL for donepezil and 0.01–50 µg/mL for rivastigmine (R² = 0.998 for both), with limits of detection of 0.04 and 0.002 µg/mL, respectively. Absolute extraction recoveries reached 83% for donepezil and 79% for rivastigmine, with enrichment factors of 10, while intra- and inter-assay precision (RSD) remained below 7.8% and 8.2%, respectively, and accuracy (RE) ranged from –6.0% to +7.1%. Clinical applicability was assessed by analyzing plasma samples from six medicated patients receiving either donepezil (5 or 10 mg/day) or rivastigmine (1.5 or 3 mg/day), with results confirming dose-proportional concentrations and demonstrating the method's suitability for routine TDM. Moreover, the procedure is rapid, with a total preparation time of less than 45 minutes, consumes minimal organic solvent (under 2 mL per sample), and adheres strictly to green analytical chemistry principles.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.